People with an underactive thyroid may have an increased risk of developing small intestinal bacterial overgrowth (SIBO), a risk that may be reduced with thyroid hormone treatment, according to a study.
Rising toxins found in bowhead whales, harvested for subsistence purposes by Alaska Native communities, reveal that ocean warming is causing higher concentrations of algal toxins in Arctic food webs.
The answer to whether tiny bacterial lifeforms really do exist in the clouds of Venus could be revealed once-and-for-all by a UK-backed mission. Scientists plan to search and map phosphine, ammonia, and other gases rich in hydrogen that shouldn’t be on the planet.
Denmark has been offering free vaccination against human papillomavirus (HPV) to girls since 2008. New data show vaccination has effectively reduced infections with cancerogenic HPV 16/18 types covered by the vaccine, indicating population immunity.
Researchers have used the platform developed for COVID-19 vaccines to create the world’s first mRNA-based vaccine against the deadly, antibiotic-resistant bacterium behind pneumonic plague.
In pre-clinical tests, compounds called batzelladins were found to be effective even against strains of Plasmodium that are resistant to conventional antimalarial drugs.
People with an underactive thyroid may have an increased risk of developing small intestinal bacterial overgrowth (SIBO), a risk that may be reduced with thyroid hormone treatment, according to a study.
Rising toxins found in bowhead whales, harvested for subsistence purposes by Alaska Native communities, reveal that ocean warming is causing higher concentrations of algal toxins in Arctic food webs.
The answer to whether tiny bacterial lifeforms really do exist in the clouds of Venus could be revealed once-and-for-all by a UK-backed mission. Scientists plan to search and map phosphine, ammonia, and other gases rich in hydrogen that shouldn’t be on the planet.
Flightpath Biosciences, Inc., has licensed a class of antibiotics developed at the University of Illinois Urbana-Champaign. The original antibiotic agent, lolamicin, effectively treated bacterial infections in animal models of disease without wiping out beneficial gut microbes.
BugBiome, an agritech innovator developing new bioinsecticides from crop-associated microbes, is field testing its lead product against aphids via a new Innovate UK grant with partner Niab, an experienced crop trial specialist.
Greentech company AFYREN offering industrial customers bio-based, low-carbon products through fermentation technology based on a circular model, announced its first plant has achieved continuous production, enabling acceleration of commercialization.
Researchers have used the platform developed for COVID-19 vaccines to create the world’s first mRNA-based vaccine against the deadly, antibiotic-resistant bacterium behind pneumonic plague.
Researchers have introduced an innovative approach to developing high-affinity receptor-containing antibodies in vitro, offering a promising strategy to combat malaria.
Scientists have developed a scalable approach to engineer bacterial cellulose into high-strength, multifunctional materials. Their biosynthesis technique aligns bacterial cellulose fibers in real-time, resulting in robust biopolymer sheets with exceptional mechanical properties.
Florida Atlantic University’s Harbor Branch Oceanographic Institute has received a $999,664 grant from FLRACEP for a three-year project titled, “Influences of Upwelling and Riverine Nutrient Plumes on the Mesophotic Coral Ecosystems of the West Florida Shelf.”
A recent update to the Human Oral Microbiome Database (HOMD) database includes a greatly expanded set of whole-genome sequences, reflecting a significant advancement in taxonomy of bacterial species and the study of microbial states in disease and health.
Applied Microbiology International has welcomed two new trustees to the AMI Board of Trustees - Dr Helen Onyeaka and Otto Balsiger. Professor Catherine Rees has been re-elected for a second term as a Trustee.